Treatment of Kaposi's sarcoma with IL-12

US6423308B1 · kind B1 · utility

Assignees

• Wyeth, LLC · US
• The United States of America, as represented by the Department of Health and Human Services · US

Inventors

• Robert Yarchoan · Bethesda, US
• James Pluda · Gaithersburg, US
• Kathleen Wyvill · Upper Marlboro, US
• Jill Lietzau · Columbia, US
• Gene M. Shearer · Bethesda, US
• Ellen Feigal · Potomac, US
• Giovanna Tosato · Bethesda, US
• Richard Little · Washington, US
• Matthew L. Sherman · Newton, US

Key dates

• Filing date: Sep 15, 1999
• Grant date: Jul 23, 2002
• Expiry date: Sep 15, 2019

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K48/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Methods are provided for using IL-12 to treat Kaposi's sarcoma (KS), particularly AIDS-associated KS.